Skip to content
Recall Observatory FDA recall evidence

Drug product

Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10

D-1362-2022

July 27, 2022

Class II

Product summary

Firm
Amneal Pharmaceuticals of New York, LLC
Event
Event 90680
Status
Terminated
Classification
Class II
Quantity
4,309 bottles
Official record key
drug-enforcement:D-1362-2022

Official wording

Reason: Failed dissolution specifications.

Code information: Lot #: AR210705, Exp 04/2024

Distribution pattern: USA nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications